Omnipod 5 FDA approval edges closer

The latest clinical trial results for the Omnipod 5 show the automated insulin delivery (AID) system can significantly increase Time in Range (TIR) and reduce the stress around managing diabetes, reports diaTribe.

Omnipod 5 is a new automated insulin delivery (AID) system that integrates the Omnipod patch pump with the Dexcom G6 continuous glucose monitor. The smart algorithm built into the patch pump links these devices and can be controlled directly from the smartphone app, unlike the previous version. This new device can predict changes in glucose levels and then automatically adjust the users’ insulin doses. The app will only be available for Android users initially, but an iPhone version is in production.

Dr Trang Ly, one of the study’s researchers and the senior vice president and medical director at Insulet, which makes the Omnipod, explains, “Improvements in HbA1c, Time in Range, and hypoglycaemia reduction were all observed over 12 months while using Omnipod 5.”

The clinical trial data is published in Diabetes Care. To read more, CLICK HERE.



Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags